AMERICAN SHARED HOSPITAL SERVICES Payments for Repurchase of Convertible Preferred Stock
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Payments for Repurchase of Convertible Preferred Stock of $14.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock · last filed 2014-03-31
- AMERICAN SHARED HOSPITAL SERVICES payments for repurchase of convertible preferred stock for the quarter ending 2013-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES payments for repurchase of convertible preferred stock for the quarter ending 2013-09-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES payments for repurchase of convertible preferred stock for the quarter ending 2012-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES payments for repurchase of convertible preferred stock for the quarter ending 2012-09-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES payments for repurchase of convertible preferred stock for fiscal 2013 was $14.00K, a 54.84% decline from fiscal 2012.
- AMERICAN SHARED HOSPITAL SERVICES payments for repurchase of convertible preferred stock for fiscal 2012 was $31.00K, a 20.51% decline from fiscal 2011.
- AMERICAN SHARED HOSPITAL SERVICES payments for repurchase of convertible preferred stock for fiscal 2011 was $39.00K.
| Period end | Payments for Repurchase of Convertible Preferred Stock 3 month | Payments for Repurchase of Convertible Preferred Stock 6 month | Payments for Repurchase of Convertible Preferred Stock 9 month | Payments for Repurchase of Convertible Preferred Stock 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $14.00K 10-K · filed 2014-03-31 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $14.00K 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $14.00K 10-Q · filed 2013-08-14 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $31.00K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $31.00K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $31.00K 10-Q · filed 2013-08-14 | |||
| 2011-12-31 | $39.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |